Top BioHealth Analyst Calls (CFN, GPRO, MD, PSYS, PMC, QLTI, ROSG, SYK, SXCI)

September 9, 2009 · Filed Under R&D 

This goes a bit beyond biotech and drug companies, but there have been many analyst research calls this morning in healthcare related stocks from drugs to genomics to IT to medical devices….  Here are the calls from this Wednesday morning:

  • CareFusion Corporation (CFN) Started as Overweight at Morgan Stanley.
  • Gen-Probe (GPRO) Raised to Outperform at Oppenheimer.
  • MEDNAX, Inc. (MD) started as Market Weight at Thomas Weisel.
  • Psychiatric Solutions (PSYS) Started as Overweight at Thomas Weisel.
  • PharMerica Corp. (PMC) Started as Market Weight at Thomas Weisel.
  • QLT Inc. (QLTI) target raised to $4.50 from $3.50 at RBC.
  • Rosetta Genomics (ROSG) Cut to Hold at Cantor Fitzgerald.
  • Stryker (SYK) Raised to Buy at Deutsche Bank.
  • SXC Health Solutions (SXCI) Raised to Outperform at William Blair.

JON C. OGG

Tags: , , , , , , , ,

Comments

Comments are closed.

    Subscribe to BioHealth Investor BioHealth Investor RSS Feed